X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs SHASUN PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH SHASUN PHARMA STERLING BIOTECH/
SHASUN PHARMA
 
P/E (TTM) x -0.4 123.9 - View Chart
P/BV x 0.0 8.5 0.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 STERLING BIOTECH   SHASUN PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
SHASUN PHARMA
Mar-14
STERLING BIOTECH/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1194 11.1%   
Low Rs346 7.5%   
Sales per share (Unadj.) Rs26.8214.2 12.5%  
Earnings per share (Unadj.) Rs-15.05.3 -280.3%  
Cash flow per share (Unadj.) Rs-5.515.8 -34.5%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs54.953.3 102.9%  
Shares outstanding (eoy) m267.8756.62 473.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.3 79.4%   
Avg P/E ratio x-0.513.1 -3.5%  
P/CF ratio (eoy) x-1.34.4 -28.8%  
Price / Book Value ratio x0.11.3 9.7%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m1,8623,958 47.0%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5472,164 25.3%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18112,127 59.2%  
Other income Rs m43229 18.6%   
Total revenues Rs m7,22312,356 58.5%   
Gross profit Rs m9471,009 93.8%  
Depreciation Rs m2,543594 428.4%   
Interest Rs m4,377415 1,054.5%   
Profit before tax Rs m-5,931230 -2,582.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-73 2,646.2%   
Profit after tax Rs m-4,007302 -1,326.1%  
Gross profit margin %13.28.3 158.5%  
Effective tax rate %32.4-31.7 -102.5%   
Net profit margin %-55.82.5 -2,239.6%  
BALANCE SHEET DATA
Current assets Rs m14,3356,884 208.2%   
Current liabilities Rs m49,8098,456 589.0%   
Net working cap to sales %-494.0-13.0 3,812.0%  
Current ratio x0.30.8 35.3%  
Inventory Days Days40362 654.5%  
Debtors Days Days171108 158.7%  
Net fixed assets Rs m55,4324,970 1,115.3%   
Share capital Rs m268113 236.5%   
"Free" reserves Rs m13,9352,875 484.7%   
Net worth Rs m14,7013,020 486.8%   
Long term debt Rs m9,4781,817 521.5%   
Total assets Rs m73,98813,347 554.3%  
Interest coverage x-0.41.6 -22.9%   
Debt to equity ratio x0.60.6 107.1%  
Sales to assets ratio x0.10.9 10.7%   
Return on assets %0.55.4 9.3%  
Return on equity %-27.310.0 -272.4%  
Return on capital %-6.413.3 -48.2%  
Exports to sales %25.946.4 55.9%   
Imports to sales %0.214.2 1.2%   
Exports (fob) Rs m1,8605,622 33.1%   
Imports (cif) Rs m121,728 0.7%   
Fx inflow Rs m1,8605,843 31.8%   
Fx outflow Rs m252,173 1.1%   
Net fx Rs m1,8353,669 50.0%   
CASH FLOW
From Operations Rs m1,719398 432.3%  
From Investments Rs m-3,148-1,635 192.6%  
From Financial Activity Rs m1,4261,309 109.0%  
Net Cashflow Rs m-371 -4.8%  

Share Holding

Indian Promoters % 33.9 39.2 86.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.6 -  
FIIs % 9.9 17.6 56.3%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 39.6 99.2%  
Shareholders   21,482 20,750 103.5%  
Pledged promoter(s) holding % 55.9 12.3 455.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   J.B.CHEMICALS  SUVEN LIFE  IPCA LABS  CADILA HEALTHCARE  VENUS REMEDIES  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Sep 17, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS